Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice
- 15 September 2008
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 377 (1), 12-16
- https://doi.org/10.1016/j.bbrc.2008.09.019
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The Interleukin‐23 / Interleukin‐17 axis in intestinal inflammationJournal of Internal Medicine, 2008
- The Biological Functions of T Helper 17 Cell Effector Cytokines in InflammationImmunity, 2008
- Th17 cells: Effector T cells with inflammatory propertiesSeminars in Immunology, 2007
- Interleukin-23 drives innate and T cell–mediated intestinal inflammationThe Journal of Experimental Medicine, 2006
- Interferon-gamma is causatively involved in experimental inflammatory bowel disease in miceClinical and Experimental Immunology, 2006
- Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Upregulation of Interleukin-12 and -17 in Active Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 2003
- T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.The Journal of Experimental Medicine, 1996
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.The Journal of Experimental Medicine, 1995
- Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosaGastroenterology, 1995